Skip to content
Idun Pharmaceuticals logo — Pioneering therapeutic solutions to control apoptosis and ad...

Idun Pharmaceuticals

Pioneering therapeutic solutions to control apoptosis and advance treatments for liver disease, CNS disorders, inflammation, and cancer.

Founded 1993 2 employees Debt Financing Total: $52.93M Biopharma, Biotechnology +1

General Information

Company Name Idun Pharmaceuticals
Founded Year 1993
Founders / Decision Makers
Team member
Employees 2
Industries Biopharma, Biotechnology, Health and Wellness
Funding Stage Debt Financing
Social

BounceWatch is an independent company data service, not affiliated with Idun Pharmaceuticals. To contact Idun Pharmaceuticals, visit idun.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Idun Pharmaceuticals compare?

A PDF of Idun Pharmaceuticals and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Idun Pharmaceuticals soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Idun Pharmaceuticals

Idun Pharmaceuticals is a biopharmaceutical company that has been pioneering therapeutic solutions to control apoptosis and advance treatments for liver disease, CNS disorders, inflammation, and cancer. Established in 1993 and headquartered in San Diego, California, the company focuses on the discovery and development of human therapeutics to manage apoptosis. It has various products in Phase 2 and preclinical trials targeting liver disease, CNS diseases, inflammation, and cancer. Notably, IDN-6556 is developed to treat liver diseases in patients with Hepatitis C virus. The company received a $1.13M Debt Financing investment on 13 July 2015. IDUN Pharmaceuticals, Inc. now operates as a subsidiary of Conatus Pharmaceuticals Inc.

Business keywords: Biopharmaceutical, Therapeutic Solutions, Apoptosis Management, Liver Disease Treatment, CNS Disorders, Inflammation Treatment, Cancer Treatment, Drug Development, Phase 2 Trials, Preclinical Trials, IDN-6556, Hepatitis C, San Diego, Conatus Pharmaceuticals, Subsidiary

Funding Rounds & Investors (5)

View All
Funding Stage Amount Investors Lead Investors Date
Debt Financing $1.13M -
13 Jul 2015
Venture Round $2.00M -
09 Feb 2015
Series B $27.00M 9
Aberdare Ventures, MPM Capital +7
15 Jun 2004
Series A $22.80M 1
Ventana Capital Management
09 Dec 2002
Seed Round Undisclosed -
01 Jan 1995

Idun Pharmaceuticals Alternatives & Competitors

View All Alternatives
Idun Pharmaceuticals vs

Embarking on a journey to better health through innovative biotechnology solutions for brain, geneti...

Post-IPO Equity
Biopharma, Biotechnology
Idun Pharmaceuticals vs
Graviton Bioscience
Graviton Bioscience United States

Curing Disease through Restored Homeostasis

Private Equity
32 employees
Biotechnology, Health and Wellness
Idun Pharmaceuticals vs

Rethinking Metabolic Health

Series C
38 employees
Biotechnology, Health Care

FAQ About Idun Pharmaceuticals

Pioneering therapeutic solutions to control apoptosis and advance treatments for liver disease, CNS disorders, inflammation, and cancer.
Idun Pharmaceuticals was founded in 1993.
Idun Pharmaceuticals operates in Biopharma, Biotechnology and Health and Wellness. Its work centres on Biopharmaceutical, Therapeutic Solutions, Apoptosis Management and Liver Disease Treatment.
Idun Pharmaceuticals has approximately 2 employees.
Idun Pharmaceuticals has completed 5 funding rounds, raising a total of $52.93M. The latest funding stage is Debt Financing.
Top alternatives and competitors to Idun Pharmaceuticals include Raptor Pharmaceuticals, Graviton Bioscience, Aardvark Therapeutics, Serina Therapeutics, Inc., TargeGen, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Idun Pharmaceuticals and Raptor Pharmaceuticals are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Idun Pharmaceuticals, https://bouncewatch.com/company/idun-pharmaceuticals, updated 14 January 2025. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout